Clinical Trial Update: Trial of Oral Glutamine on Mitochondrial Function in CKD [Phase 2]

View source ↗

Summary

Phase 2 trial assessing oral glutamine effects on mitochondrial function in CKD; study completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Chronic Kidney Disease
• Endothelial Dysfunction
• Sarcopenia

Drugs mentioned

• Glutamine (glutamine)

Snippet

Sponsor: University of Washington | Conditions: Cardiovascular Disease, Sarcopenia | Phase 2 | Status: COMPLETED | Results posted: 2022-07-14